Clinical Trial Update: High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4 [Phase 3]

View source ↗

Summary

This entry documents a Phase 3 trial evaluating high-dose ribavirin for chronic hepatitis C genotype 1 or 4, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Chronic Hepatitis C | Phase 3 | Status: TERMINATED